
Meta Platforms reiterated its warning that it may have to pull its popular Facebook and Instagram services from the European Union if a new transatlantic data transfer pact doesn’t materialize.
Meta could face a ban on its practice of exporting user data to the U.S. for which it is currently under scrutiny by Ireland’s data protection watchdog. The issue surrounds EU-U.S. data transfers that take place under standard contractual clauses (SCCs).
The EU and U.S. in March broke a deadlock to reach a tentative deal on a new data-transfer pact after a previous accord was struck down by the bloc’s top court over concerns U.S. agencies could snoop on the information without adequate privacy safeguards.
Negotiations on a new pact won’t likely conclude before next year, by which time the Irish watchdog may have already issued its ban.
“If a new transatlantic data transfer framework is not adopted and we are unable to continue to rely on SCCs or rely upon other alternative means of data transfers from the EU to the US, we will likely be unable to offer a number of our most significant products and services, including Facebook and Instagram, in Europe,” Meta said in a U.S. regulatory filing.
This “would materially and adversely affect our business, financial condition, and results of operations,” it added.
The unanswered questions over data transfers stem from a 2020 ruling by the EU’s highest court that ended the EU-U.S. Privacy Shield agreement over long standing fears that it exposed EU citizens to illegal surveillance by U.S. intelligence agencies.
Up until now, SCCs have acted as a workaround to the EU’s toppling of the Privacy Shield but it appears that era is coming to an end.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas